Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

被引：0
|
作者：
Sita Sirisha Madugula
Selvaraman Nagamani
Esther Jamir
Lipsa Priyadarsinee
G. Narahari Sastry
机构：
[1] CSIR-Indian Institute of Chemical Technology,Centre for Molecular Modelling
[2] Academy of Scientific and Innovative Research (AcSIR),Advanced Computation and Data Sciences Division
[3] CSIR – North East Institute of Science and Technology,undefined
来源：
Molecular Diversity | 2022年 / 26卷
关键词：
targets; Drug repositioning; Polypharmacology; Virtual screening; PASS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1675 / 1695
页数：20
相关论文
共 50 条
  • [31] Pharmacokinetics of Anti-tuberculosis Drugs in Children
    Ramachandran, Geetha
    Kumar, A. K. Hemanth
    Swaminathan, Soumya
    INDIAN JOURNAL OF PEDIATRICS, 2011, 78 (04): : 435 - 442
  • [32] Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs
    Ko, Younhee
    Lee, Chulho
    Lee, Youngmok
    Lee, Jin-Sung
    DIAGNOSTICS, 2019, 9 (04)
  • [33] INTERACTION OF DIAZEPAM WITH ANTI-TUBERCULOSIS DRUGS
    OCHS, HR
    GREENBLATT, DJ
    ROBERTS, GM
    DENGLER, HJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 270 - 270
  • [34] Drug-drug interaction studies on first-line anti-tuberculosis drugs
    Bhutani, H
    Singh, S
    Jindal, KC
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (04) : 517 - 524
  • [35] Anti-tuberculosis drug resistance in Portugal
    Antunes, ML
    Aleixo-Dias, J
    Antunes, AF
    Pereira, MF
    Raymundo, E
    Rodrigues, MF
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (03) : 223 - 231
  • [36] PYRAZINAMIDE IS A MAJOR ANTI-TUBERCULOSIS DRUG
    PRETET, S
    LIARD, R
    PERDRIZET, S
    LANCET, 1982, 1 (8268): : 399 - 399
  • [37] NEUROTOXICITY OF ETHAMBUTOL ANTI-TUBERCULOSIS DRUG
    SCHMIDT, I
    ANATOMICAL RECORD, 1964, 148 (02): : 333 - &
  • [38] Polypharmacology guided drug repositioning approach for SARS-CoV2
    Jamir, Esther
    Sarma, Himakshi
    Priyadarsinee, Lipsa
    Kiewhuo, Kikrusenuo
    Nagamani, Selvaraman
    Sastry, G. Narahari
    PLOS ONE, 2023, 18 (08):
  • [39] Clay minerals-based drug delivery systems for anti-tuberculosis drugs
    Saadat, Saeida
    Rawtani, Deepak
    Parikh, Garvita
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 76
  • [40] Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions
    Lehloenya, R. J.
    Todd, G.
    Badri, M.
    Dheda, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (12) : 1649 - 1655
12345